Engineering organs

Current Opinion in Biotechnology

Volumn 20, Issue 5, 2009, Pages 575-592

  Atala, Anthony ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL TRANSPLANTATION; CLINICAL PROBLEMS; CLINICAL SETTINGS; MATERIAL SCIENCE; NORMAL FUNCTION; ORGAN FAILURE; REGENERATIVE MEDICINE; STEM CELL; THERAPEUTIC CLONING; TISSUE ENGINEERING APPLICATIONS;

CELLS; CLONING; SAFETY ENGINEERING;

TISSUE ENGINEERING;

BIOMATERIAL; TESTOSTERONE;

BIOENGINEERING; BLADDER SURGERY; BLOOD VESSEL GRAFT; CELL CLONING; CELL NUCLEUS TRANSPLANTATION; CELL THERAPY; CELL TRANSPLANTATION; GYNECOLOGIC DISEASE; HEART DISEASE; HUMAN; KIDNEY DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; NONHUMAN; ORGAN DONOR; ORGAN INJURY; ORGAN TRANSPLANTATION; PLASTIC SURGERY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; STEM CELL TRANSPLANTATION; TESTIS DISEASE; TISSUE ENGINEERING; TISSUE REGENERATION; URETHRA SURGERY; UROLOGIC SURGERY;

ANIMALS; ARTIFICIAL ORGANS; BIOCOMPATIBLE MATERIALS; HUMANS; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 70449643153     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2009.10.003     Document Type: Review

References (178)

1. Carrel A., and Lindbergh C.A. The culture of whole organs. Science 81 (1935) 621-623
2. Guild W.R., Harrison J.H., Merrill J.P., and Murray J. Successful homotransplantation of the kidney in an identical twin. Trans Am Clin Climatol Assoc 67 (1955) 167-173
3. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 78 (1981) 7634-7638
4. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., and Jones J.M. Embryonic stem cell lines derived from human blastocysts. [see comment]. Science 282 (1998) 1145-1147 [Erratum in Science 1998;282(5395):1827]
5. Wilmut I., Schnieke A.E., McWhir J., Kind A.J., and Campbell K.H. Viable offspring derived from fetal and adult mammalian cells. [see comment]. Nature 385 (1997) 810-813 [Erratum in Nature 1997;386(6621):200]
6. Haseltine W. A brave new medicine. A conversation with William Haseltine Interview by Joe Flower. Health Forum J 42 (1999) 28-30
7. Brivanlou A.H., Gage F.H., Jaenisch R., Jessell T., Melton D., and Rossant J. Stem cells. Setting standards for human embryonic stem cells. [see comment]. Science 300 (2003) 913-916
8. Richards M., Fong C.Y., Chan W.K., Wong P.C., and Bongso A. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. [see comment]. Nat Biotechnol 20 (2002) 933-936
9. Amit M., Shariki C., Margulets V., and Itskovitz-Eldor J. Feeder layer- and serum-free culture of human embryonic stem cells. Biol Reprod 70 (2004) 837-845
10. Reubinoff B.E., Pera M.F., Fong C.Y., Trounson A., and Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. [see comment]. Nat Biotechnol 18 (2000) 399-404 [Erratum in Nat Biotechnol 2000;18(5):559]
11. Reubinoff B.E., Itsykson P., Turetsky T., Pera M.F., Reinhartz E., Itzik A., and Ben-Hur T. Neural progenitors from human embryonic stem cells. [see comment]. Nat Biotechnol 19 (2001) 1134-1140
12. Schuldiner M., Eiges R., Eden A., Yanuka O., Itskovitz-Eldor J., Goldstein R.S., and Benvenisty N. Induced neuronal differentiation of human embryonic stem cells. Brain Res 913 (2001) 201-205
13. Schuldiner M., Yanuka O., Itskovitz-Eldor J., Melton D.A., and Benvenisty N. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 97 (2000) 11307-11312
14. Zhang S.C., Wernig M., Duncan I.D., Brustle O., and Thomson J.A. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. [see comment]. Nat Biotechnol 19 (2001) 1129-1133
15. Kaufman D.S., Hanson E.T., Lewis R.L., Auerbach R., and Thomson J.A. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 98 (2001) 10716-10721
16. Kehat I., Kenyagin-Karsenti D., Snir M., Segev H., Amit M., Gepstein A., Livne E., Binah O., Itskovitz-Eldor J., and Gepstein L. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. [see comment]. J Clin Invest 108 (2001) 407-414
17. Levenberg S., Golub J.S., Amit M., Itskovitz-Eldor J., and Langer R. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 99 (2002) 4391-4396
18. Assady S., Maor G., Amit M., Itskovitz-Eldor J., Skorecki K.L., and Tzukerman M. Insulin production by human embryonic stem cells. Diabetes 50 (2001) 1691-1697
19. Itskovitz-Eldor J., Schuldiner M., Karsenti D., Eden A., Yanuka O., Amit M., Soreq H., and Benvenisty N. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 6 (2000) 88-95
20. Colman A., and Kind A. Therapeutic cloning: concepts and practicalities. Trends Biotechnol 18 (2000) 192-196
21. Vogelstein B., Alberts B., and Shine K. Genetics. Please don't call it cloning!. [see comment]. Science 295 (2002) 1237
22. Hochedlinger K., Rideout W.M., Kyba M., Daley G.Q., Blelloch R., and Jaenisch R. Nuclear transplantation, embryonic stem cells and the potential for cell therapy. Hematol J 5 Suppl 3 (2004) S114-S117
23. Dinnyes A., De Sousa P., King T., and Wilmut I. Somatic cell nuclear transfer: recent progress and challenges. Clon Stem Cells 4 (2002) 81-90
24. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
25. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., Bernstein B.E., and Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448 (2007) 318-324
26. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., and Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 861-872
27. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318 (2007) 1917-1920
28. De Coppi P., Bartsch Jr. G., Siddiqui M.M., Xu T., Santos C.C., Perin L., Mostoslavsky G., Serre A.C., Snyder E.Y., Yoo J.J., et al. Isolation of amniotic stem cell lines with potential for therapy. [see comment]. Nat Biotechnol 25 (2007) 100-106
29. Ballas C.B., Zielske S.P., and Gerson S.L. Adult bone marrow stem cells for cell and gene therapies: implications for greater use. J Cell Biochem Suppl 38 (2002) 20-28
30. Jiao J., and Chen D.F. Induction of neurogenesis in nonconventional neurogenic regions of the adult central nervous system by niche astrocyte-produced signals. Stem Cells 26 (2008) 1221-1230
31. Taupin P. Therapeutic potential of adult neural stem cells. Recent Patents CNS Drug Discov 1 (2006) 299-303
32. Jensen U.B., Yan X., Triel C., Woo S.H., Christensen R., and Owens D.M. A distinct population of clonogenic and multipotent murine follicular keratinocytes residing in the upper isthmus. J Cell Sci 121 (2008) 609-617
33. Crisan M., Casteilla L., Lehr L., Carmona M., Paoloni-Giacobino A., Yap S., Sun B., Leger B., Logar A., Penicaud L., et al. A reservoir of brown adipocyte progenitors in human skeletal muscle. Stem Cells 26 (2008) 2425-2433
34. Weiner L.P. Definitions and criteria for stem cells. Methods Mol Biol 438 (2008) 3-8
35. Cilento B.G., Freeman M.R., Schneck F.X., Retik A.B., and Atala A. Phenotypic and cytogenetic characterization of human bladder urothelia expanded in vitro. J Urol 152 (1994) 665-670
36. Scriven S.D., Booth C., Thomas D.F., Trejdosiewicz L.K., and Southgate J. Reconstitution of human urothelium from monolayer cultures. J Urol 158 (1997) 1147-1152
37. Liebert M., Hubbel A., Chung M., Wedemeyer G., Lomax M.I., Hegeman A., Yuan T.Y., Brozovich M., Wheelock M.J., and Grossman H.B. Expression of mal is associated with urothelial differentiation in vitro: identification by differential display reverse-transcriptase polymerase chain reaction. Differentiation 61 (1997) 177-185
38. Puthenveettil J.A., Burger M.S., and Reznikoff C.A. Replicative senescence in human uroepithelial cells. Adv Exp Med Biol 462 (1999) 83-91
39. Atala A., Vacanti J.P., Peters C.A., Mandell J., Retik A.B., and Freeman M.R. Formation of urothelial structures in vivo from dissociated cells attached to biodegradable polymer scaffolds in vitro. J Urol 148 (1992) 658-662
40. Atala A., Cima L.G., Kim W., Paige K.T., Vacanti J.P., Retik A.B., and Vacanti C.A. Injectable alginate seeded with chondrocytes as a potential treatment for vesicoureteral reflux. J Urol 150 (1993) 745-747
41. Atala A., Freeman M.R., Vacanti J.P., Shepard J., and Retik A.B. Implantation in vivo and retrieval of artificial structures consisting of rabbit and human urothelium and human bladder muscle. J Urol 150 (1993) 608-612
42. Atala A., Kim W., Paige K.T., Vacanti C.A., and Retik A.B. Endoscopic treatment of vesicoureteral reflux with a chondrocyte-alginate suspension. J Urol 152 (1994) 641-643 [discussion 644]
43. Atala A., Schlussel R.N., and Retik A.B. Renal cell growth in vivo after attachment to biodegradable polymer scaffolds. J Urol 153 (1995)
44. Atala A., Guzman L., and Retik A.B. A novel inert collagen matrix for hypospadias repair. J Urol 162 (1999) 1148-1151
45. Atala A. Tissue engineering in the genitourinary system. In: Atala A., and Mooney D.J. (Eds). Tissue Engineering (1997), Birkhauser Press 149
46. Atala A. Autologous cell transplantation for urologic reconstruction. J Urol 159 (1998) 2-3
47. Yoo J.J., and Atala A. A novel gene delivery system using urothelial tissue engineered neo-organs. J Urol 158 (1997) 1066-1070
48. Fauza D.O., Fishman S.J., Mehegan K., and Atala A. Videofetoscopically assisted fetal tissue engineering: skin replacement. J Pediatr Surg 33 (1998) 357-361
49. Fauza D.O., Fishman S.J., Mehegan K., and Atala A. Videofetoscopically assisted fetal tissue engineering: bladder augmentation. J Pediatr Surg 33 (1998) 7-12
50. Machluf M., and Atala A. Emerging concepts for tissue and organ transplantation. Graft 1 (1998) 31-37
51. Yoo J.J., Meng J., Oberpenning F., and Atala A. Bladder augmentation using allogenic bladder submucosa seeded with cells. Urology 51 (1998) 221-225
52. Amiel G.E., and Atala A. Current and future modalities for functional renal replacement. Urol Clin N Am 26 (1999) 235-246
53. Kershen R.T., and Atala A. New advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux. Urol Clin N Am 26 (1999) 81-94
54. Oberpenning F., Meng J., Yoo J.J., and Atala A. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. [see comment]. Nat Biotechnol 17 (1999) 149-155
55. Park H.J., Yoo J.J., Kershen R.T., Moreland R., and Atala A. Reconstitution of human corporal smooth muscle and endothelial cells in vivo. J Urol 162 (1999) 1106-1109
56. Liebert M., Wedemeyer G., Abruzzo L.V., Kunkel S.L., Hammerberg C., Cooper K.D., and Grossman H.B. Stimulated urothelial cells produce cytokines and express an activated cell surface antigenic phenotype. Semin Urol 9 (1991) 124-130
57. Tobin M.S., Freeman M.R., and Atala A. Maturational response of normal human urothelial cells in culture is dependent on extracellular matrix and serum additives. Surg Forum 45 (1994) 786
58. Harriss D.R. Smooth muscle cell culture: a new approach to the study of human detrusor physiology and pathophysiology. Br J Urol 75 Suppl 1 (1995) 18-26
59. Freeman M.R., Yoo J.J., Raab G., Soker S., Adam R.M., Schneck F.X., Renshaw A.A., Klagsbrun M., and Atala A. Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder. J Clin Invest 99 (1997) 1028-1036
60. Solomon L.Z., Jennings A.M., Sharpe P., Cooper A.J., and Malone P.S. Effects of short-chain fatty acids on primary urothelial cells in culture: implications for intravesical use in enterocystoplasties. [see comment]. J Lab Clin Med 132 (1998) 279-283
61. Lobban E.D., Smith B.A., Hall G.D., Harnden P., Roberts P., Selby P.J., Trejdosiewicz L.K., and Southgate J. Uroplakin gene expression by normal and neoplastic human urothelium. Am J Pathol 153 (1998) 1957-1967
62. Nguyen H.T., Park J.M., Peters C.A., Adam R.M., Orsola A., Atala A., and Freeman M.R. Cell-specific activation of the HB-EGF and ErbB1 genes by stretch in primary human bladder cells. In Vitro Cell Dev Biol Anim 35 (1999) 371-375
63. Rackley R.R., Bandyopadhyay S.K., Fazeli-Matin S., Shin M.S., and Appell R. Immunoregulatory potential of urothelium: characterization of NF-kappaB signal transduction. J Urol 162 (1999) 1812-1816
64. Kim B.S., and Mooney D.J. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol 16 (1998) 224-230
65. Li S.T. Biologic biomaterials: tissue derived biomaterials (collagen). In: JD B. (Ed). The Biomedical Engineering Handbook (1995), CRS Press 627-647
66. Furthmayr H., and Timpl R. Immunochemistry of collagens and procollagens. Int Rev Connect Tissue Res 7 (1976) 61-99
67. Cen L., Liu W., Cui L., Zhang W., and Cao Y. Collagen tissue engineering: development of novel biomaterials and applications. Pediatr Res 63 (2008) 492-496
68. Yannas I.V., Burke J.F., Gordon P.L., Huang C., and Rubenstein R.H. Design of an artificial skin. II. Control of chemical composition. J Biomed Mater Res 14 (1980) 107-132
69. Yannas I.V., and Burke J.F. Design of an artificial skin. I. Basic design principles. J Biomed Mater Res 14 (1980) 65-81
70. Cavallaro J.F., Kemp P.D., and Kraus K.H. Collagen fabrics as biomaterials. Biotechnol Bioeng 43 (1994) 781-791
71. Smidsrod O., and Skjak-Braek G. Alginate as immobilization matrix for cells. Trends Biotechnol 8 (1990) 71-78
72. Rowley J.A., Madlambayan G., and Mooney D.J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20 (1999) 45-53
73. Campbell P.G., and Weiss L.E. Tissue engineering with the aid of inkjet printers. Expert Opin Biol Ther 7 (2007) 1123-1127
74. Boland T., Xu T., Damon B., and Cui X. Application of inkjet printing to tissue engineering. Biotechnol J 1 (2006) 910-917
75. Nakamura M., Kobayashi A., Takagi F., Watanabe A., Hiruma Y., Ohuchi K., Iwasaki Y., Horie M., Morita I., and Takatani S. Biocompatible inkjet printing technique for designed seeding of individual living cells. Tissue Eng 11 (2005) 1658-1666
76. Laflamme M.A., Gold J., Xu C., Hassanipour M., Rosler E., Police S., Muskheli V., and Murry C.E. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 167 (2005) 663-671
77. Xu T., Rohozinski J., Zhao W., Moorefield E.C., Atala A., and Yoo J.J. Inkjet-mediated gene transfection into living cells combined with targeted delivery. Tissue Eng Part A 15 (2009) 95-101
78. Ilkhanizadeh S., Teixeira A.I., and Hermanson O. Inkjet printing of macromolecules on hydrogels to steer neural stem cell differentiation. Biomaterials 28 (2007) 3936-3943
79. Roth E.A., Xu T., Das M., Gregory C., Hickman J.J., and Boland T. Inkjet printing for high-throughput cell patterning. Biomaterials 25 (2004) 3707-3715
80. Dahms S.E., Piechota H.J., Dahiya R., Lue T.F., and Tanagho E.A. Composition and biomechanical properties of the bladder acellular matrix graft: comparative analysis in rat, pig and human. Br J Urol 82 (1998) 411-419
81. Piechota H.J., Dahms S.E., Nunes L.S., Dahiya R., Lue T.F., and Tanagho E.A. In vitro functional properties of the rat bladder regenerated by the bladder acellular matrix graft. J Urol 159 (1998) 1717-1724
82. Chen F., Yoo J.J., and Atala A. Acellular collagen matrix as a possible "off the shelf" biomaterial for urethral repair. Urology 54 (1999) 407-410
83. Probst M., Dahiya R., Carrier S., and Tanagho E.A. Reproduction of functional smooth muscle tissue and partial bladder replacement. Br J Urol 79 (1997) 505-515
84. Gilding D. Biodegradable polymers. In: Williams D. (Ed). Biocompatibility of Clinical Implant Materials (1981), CRC Press 209-232
85. Freed L.E., Vunjak-Novakovic G., Biron R.J., Eagles D.B., Lesnoy D.C., Barlow S.K., and Langer R. Biodegradable polymer scaffolds for tissue engineering. Biotechnology (NY) 12 (1994) 689-693
86. Mikos A.G., Lyman M.D., Freed L.E., and Langer R. Wetting of poly(l-lactic acid) and poly(dl-lactic-co-glycolic acid) foams for tissue culture. Biomaterials 15 (1994) 55-58
87. Harris L.D., Kim B.S., and Mooney D.J. Open pore biodegradable matrices formed with gas foaming. J Biomed Mater Res 42 (1998) 396-402
88. Han D., and Gouma P.I. Electrospun bioscaffolds that mimic the topology of extracellular matrix. Nanomedicine 2 (2006) 37-41
89. Choi J.S., Lee S.J., Christ G.J., Atala A., and Yoo J.J. The influence of electrospun aligned poly(epsilon-caprolactone)/collagen nanofiber meshes on the formation of self-aligned skeletal muscle myotubes. Biomaterials 29 (2008) 2899-2906
90. Lee S.J., Liu J., Oh S.H., Soker S., Atala A., and Yoo J.J. Development of a composite vascular scaffolding system that withstands physiological vascular conditions. Biomaterials 29 (2008) 2891-2898
91. Lee S.J., Oh S.H., Liu J., Soker S., Atala A., and Yoo J.J. The use of thermal treatments to enhance the mechanical properties of electrospun poly(epsilon-caprolactone) scaffolds. Biomaterials 29 (2008) 1422-1430
92. Barrera D.A., Zylstra E., Lansbury P.T., and Langer R. Synthesis and RGD peptide modification of a new biodegradable copolymer poly (lactic acid-co-lysine). J Am Chem Soc 115 (1993) 11010-11011
93. Cook A.D., Hrkach J.S., Gao N.N., Johnson I.M., Pajvani U.B., Cannizzaro S.M., and Langer R. Characterization and development of RGD-peptide-modified poly(lactic acid-co-lysine) as an interactive, resorbable biomaterial. J Biomed Mater Res 35 (1997) 513-523
94. Intveld P.J.A., Shen Z.R., and Takens G.A.J. Glycine glycolic acid based copolymers. J Polym Sci Polym Chem 32 (1994) 1063-1069
95. Peppas N.A., and Langer R. New challenges in biomaterials. [see comment]. Science 263 (1994) 1715-1720
96. Boccaccini A.R., and Blaker J.J. Bioactive composite materials for tissue engineering scaffolds. Expert Rev Med Devices 2 (2005) 303-317
97. Harrison B.S., and Atala A. Carbon nanotube applications for tissue engineering. Biomaterials 28 (2007) 344-353
98. Harrington D.A., Cheng E.Y., Guler M.O., Lee L.K., Donovan J.L., Claussen R.C., and Stupp S.I. Branched peptide-amphiphiles as self-assembling coatings for tissue engineering scaffolds. J Biomed Mater Res A 78 (2006) 157-167
99. Bazeed M.A., Thuroff J.W., Schmidt R.A., and Tanagho E.A. New treatment for urethral strictures. Urology 21 (1983) 53-57
100. Olsen L., Bowald S., Busch C., Carlsten J., and Eriksson I. Urethral reconstruction with a new synthetic absorbable device. An experimental study. Scand J Urol Nephrol 26 (1992) 323-326
101. Sievert K.D., Bakircioglu M.E., Nunes L., Tu R., Dahiya R., and Tanagho E.A. Homologous acellular matrix graft for urethral reconstruction in the rabbit: histological and functional evaluation. J Urol 163 (2000) 1958-1965
102. El-Kassaby A.W., Retik A.B., Yoo J.J., and Atala A. Urethral stricture repair with an off-the-shelf collagen matrix. J Urol 169 (2003) 170-173 [discussion 173]
103. El-Kassaby A., Aboushwareb T., and Atala A. Randomized comparative study between buccal mucosal and acellular bladder matrix grafts in complex anterior urethral strictures. J Urol 179 (2008) 1432-1436
104. De Filippo R.E., Yoo J.J., and Atala A. Urethral replacement using cell seeded tubularized collagen matrices. J Urol 168 (2002) 1789-1792 [discussion 1792-1783]
105. le Roux P.J. Endoscopic urethroplasty with unseeded small intestinal submucosa collagen matrix grafts: a pilot study. J Urol 173 (2005) 140-143
106. Fu Q., Deng C.L., Liu W., and Cao Y.L. Urethral replacement using epidermal cell-seeded tubular acellular bladder collagen matrix. BJU Int 99 (2007) 1162-1165
107. Li C., Xu Y., Song L., Fu Q., Cui L., and Yin S. Preliminary experimental study of tissue-engineered urethral reconstruction using oral keratinocytes seeded on BAMG. Urol Int 81 (2008) 290-295
108. Guan Y., Ou L., Hu G., Wang H., Xu Y., Chen J., Zhang J., Yu Y., and Kong D. Tissue engineering of urethra using human vascular endothelial growth factor gene-modified bladder urothelial cells. Artif Organs 32 (2008) 91-99
109. Dorin R.P., Pohl H.G., De Filippo R.E., Yoo J.J., and Atala A. Tubularized urethral replacement with unseeded matrices: what is the maximum distance for normal tissue regeneration?. World J Urol 26 (2008) 323-326
110. Atala A. Commentary on the replacement of urologic associated mucosa. J Urol 156 (1995) 338
111. Sutherland R.S., Baskin L.S., Hayward S.W., and Cunha G.R. Regeneration of bladder urothelium, smooth muscle, blood vessels and nerves into an acellular tissue matrix. J Urol 156 (1996) 571-577
112. Wefer J., Sievert K.D., Schlote N., Wefer A.E., Nunes L., Dahiya R., Gleason C.A., and Tanagho E.A. Time dependent smooth muscle regeneration and maturation in a bladder acellular matrix graft: histological studies and in vivo functional evaluation. J Urol 165 (2001) 1755-1759
113. Kropp B.P., Sawyer B.D., Shannon H.E., Rippy M.K., Badylak S.F., Adams M.C., Keating M.A., Rink R.C., and Thor K.B. Characterization of small intestinal submucosa regenerated canine detrusor: assessment of reinnervation, in vitro compliance and contractility. J Urol 156 (1996) 599-607
114. Jayo M.J., Jain D., Wagner B.J., and Bertram T.A. Early cellular and stromal responses in regeneration versus repair of a mammalian bladder using autologous cell and biodegradable scaffold technologies. [see comment]. J Urol 180 (2008) 392-397
115. Zhang Y. Bladder reconstruction by tissue engineering - with or without cells?. [see comment]. J Urol 180 (2008) 10-11
116. Chun S.Y., Lim G.J., Kwon T.G., Kwak E.K., Kim B.W., Atala A., and Yoo J.J. Identification and characterization of bioactive factors in bladder submucosa matrix. Biomaterials 28 (2007) 4251-4256
117. Kikuno N., Kawamoto K., Hirata H., Vejdani K., Kawakami K., Fandel T., Nunes L., Urakami S., Shiina H., Igawa M., et al. Nerve growth factor combined with vascular endothelial growth factor enhances regeneration of bladder acellular matrix graft in spinal cord injury-induced neurogenic rat bladder. BJU Int 103 (2008) 1424-1428
118. de Boer W.I., Schuller A.G., Vermey M., and van der Kwast T.H. Expression of growth factors and receptors during specific phases in regenerating urothelium after acute injury in vivo. Am J Pathol 145 (1994) 1199-1207
119. Baker R., Kelly T., Tehan T., Putnam C., and Beaugard E. Subtotal cystectomy and total bladder regeneration in treatment of bladder cancer. J Am Med Assoc 168 (1958) 1178-1185
120. Gorham S.D., French D.A., Shivas A.A., and Scott R. Some observations on the regeneration of smooth muscle in the repaired urinary bladder of the rabbit. Eur Urol 16 (1989) 440-443
121. Master V.A., Wei G., Liu W., and Baskin L.S. Urothlelium facilitates the recruitment and trans-differentiation of fibroblasts into smooth muscle in acellular matrix. J Urol 170 (2003) 1628-1632
122. Jayo M.J., Jain D., Ludlow J.W., Payne R., Wagner B.J., McLorie G., and Bertram T.A. Long-term durability, tissue regeneration and neo-organ growth during skeletal maturation with a neo-bladder augmentation construct. Regener Med 3 (2008) 671-682
123. Kwon T.G., Yoo J.J., and Atala A. Local and systemic effects of a tissue engineered neobladder in a canine cystoplasty model. J Urol 179 (2008) 2035-2041
124. Zhang Y., Frimberger D., Cheng E.Y., Lin H.K., and Kropp B.P. Challenges in a larger bladder replacement with cell-seeded and unseeded small intestinal submucosa grafts in a subtotal cystectomy model. BJU Int 98 (2006) 1100-1105
125. Farhat W.A., and Yeger H. Does mechanical stimulation have any role in urinary bladder tissue engineering?. World J Urol 26 (2008) 301-305
126. Atala A., Bauer S.B., Soker S., Yoo J.J., and Retik A.B. Tissue-engineered autologous bladders for patients needing cystoplasty. [see comment]. Lancet 367 (2006) 1241-1246
127. Lin H.K., Cowan R., Moore P., Zhang Y., Yang Q., Peterson Jr. J.A., Tomasek J.J., Kropp B.P., and Cheng E.Y. Characterization of neuropathic bladder smooth muscle cells in culture. J Urol 171 (2004) 1348-1352
128. Hipp J., Andersson K.E., Kwon T.G., Kwak E.K., Yoo J., and Atala A. Microarray analysis of exstrophic human bladder smooth muscle. BJU Int 101 (2008) 100-105
129. Dozmorov M.G., Kropp B.P., Hurst R.E., Cheng E.Y., and Lin H.K. Differentially expressed gene networks in cultured smooth muscle cells from normal and neuropathic bladder. J Smooth Muscle Res 43 (2007) 55-72
130. Lai J.Y., Yoon C.Y., Yoo J.J., Wulf T., and Atala A. Phenotypic and functional characterization of in vivo tissue engineered smooth muscle from normal and pathological bladders. J Urol 168 (2002) 1853-1857 [discussion 1858]
131. Faris R.A., Konkin T., and Halpert G. Liver stem cells: a potential source of hepatocytes for the treatment of human liver disease. [see comment]. Artif Organs 25 (2001) 513-521
132. Haller H., de Groot K., Bahlmann F., Elger M., and Fliser D. Stem cells and progenitor cells in renal disease. Kidney Int 68 (2005) 1932-1936
133. Frumpkin A.P. Reconstruction of male genitalia. Am Rev Sov Med 2 (1944) 14
134. Goodwin W.E., Scott W.W., and Phalloplasty. J Urol 68 (1952) 903-908
135. Bretan P.N. History of prosthetic treatment of impotence. In: Montague D.K. (Ed). Genitourinary Prostheses (1989), WB Saunders 1-5
136. Small M.P., Carrion H.M., and Gordon J.A. Small-Carrion penile prosthesis. New implant for management of impotence. Urology 5 (1975) 479-486
137. Thomalla J.V., Thompson S.T., Rowland R.G., and Mulcahy J.J. Infectious complications of penile prosthetic implants. J Urol 138 (1987) 65-67
138. Nukui F., Okamoto S., Nagata M., Kurokawa J., and Fukui J. Complications and reimplantation of penile implants. Int J Urol 4 (1997) 52-54
139. Jordan G.H. Penile reconstruction, phallic construction, and urethral reconstruction. Urol Clin N Am 26 (1999) 1-13
140. Kershen R.T., Yoo J.J., Moreland R.B., Krane R.J., and Atala A. Reconstitution of human corpus cavernosum smooth muscle in vitro and in vivo. Tissue Eng 8 (2002) 515-524
141. Falke G., Yoo J.J., Kwon T.G., Moreland R., and Atala A. Formation of corporal tissue architecture in vivo using human cavernosal muscle and endothelial cells seeded on collagen matrices. Tissue Eng 9 (2003) 871-879
142. Kwon T.G., Yoo J.J., and Atala A. Autologous penile corpora cavernosa replacement using tissue engineering techniques. J Urol 168 (2002) 1754-1758
143. Raya-Rivera A.M., Baez C., Atala A., and Yoo J.J. Tissue engineered testicular prostheses with prolonged testosterone release. World J Urol 26 (2008) 307-314
144. Wang T, Koh C, Yoo JJ: Creation of an engineered uterus for surgical reconstruction. In American Academy of Pediatrics Section on Urology; 2003.
145. Wefer J., Sekido N., Sievert K.D., Schlote N., Nunes L., Dahiya R., Jonas U., and Tanagho E.A. Homologous acellular matrix graft for vaginal repair in rats: a pilot study for a new reconstructive approach. World J Urol 20 (2002) 260-263
146. De Filippo R.E., Yoo J.J., and Atala A. Engineering of vaginal tissue in vivo. Tissue Eng 9 (2003) 301-306
147. De Filippo R.E., Bishop C.E., Filho L.F., Yoo J.J., and Atala A. Tissue engineering a complete vaginal replacement from a small biopsy of autologous tissue. Transplantation 86 (2008) 208-214 [Erratum in Transplantation 2008;86(5):751. Note: De Philippo, Roger E (corrected to De Filippo, Roger E)]
148. Ikarashi K., Li B., Suwa M., Kawamura K., Morioka T., Yao J., Khan F., Uchiyama M., and Oite T. Bone marrow cells contribute to regeneration of damaged glomerular endothelial cells. Kidney Int 67 (2005) 1925-1933
149. Kale S., Karihaloo A., Clark P.R., Kashgarian M., Krause D.S., and Cantley L.G. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest 112 (2003) 42-49
150. Lin F., Cordes K., Li L., Hood L., Couser W.G., Shankland S.J., and Igarashi P. Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 14 (2003) 1188-1199
151. Lin F., Moran A., and Igarashi P. Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest 115 (2005) 1756-1764
152. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276 (1997) 71-74
153. Yokoo T., Ohashi T., Shen J.S., Sakurai K., Miyazaki Y., Utsunomiya Y., Takahashi M., Terada Y., Eto Y., Kawamura T., et al. Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissues. Proc Natl Acad Sci U S A 102 (2005) 3296-3300
154. Carley W.W., Milici A.J., and Madri J.A. Extracellular matrix specificity for the differentiation of capillary endothelial cells. Exp Cell Res 178 (1988) 426-434
155. Humes H.D., and Cieslinski D.A. Interaction between growth factors and retinoic acid in the induction of kidney tubulogenesis in tissue culture. Exp Cell Res 201 (1992) 8-15
156. Milici A.J., Furie M.B., and Carley W.W. The formation of fenestrations and channels by capillary endothelium in vitro. Proc Natl Acad Sci U S A 82 (1985) 6181-6185
157. Schena F.P. Role of growth factors in acute renal failure. Kidney Int Suppl 66 (1998) S11-15
158. Aboushwareb T., Egydio F., Straker L., Gyabaah K., Atala A., and Yoo J.J. Erythropoietin producing cells for potential cell therapy. World J Urol 26 (2008) 295-300
159. Lanza R.P., Chung H.Y., Yoo J.J., Wettstein P.J., Blackwell C., Borson N., Hofmeister E., Schuch G., Soker S., Moraes C.T., et al. Generation of histocompatible tissues using nuclear transplantation. Nat Biotechnol 20 (2002) 689-696
160. Folkman J., and Hochberg M. Self-regulation of growth in three dimensions. J Exp Med 138 (1973) 745-753
161. Tachibana M., Nagamatsu G.R., and Addonizio J.C. Ureteral replacement using collagen sponge tube grafts. J Urol 133 (1985) 866-869
162. Murray M.M., Forsythe B., Chen F., Lee S.J., Yoo J.J., Atala A., and Steinert A. The effect of thrombin on ACL fibroblast interactions with collagen hydrogels. J Orthop Res 24 (2006) 508-515
163. Fung L.C.T., Elenius K., Freeman M., Donovan M.J., and Atala A. Reconstitution of poor EGFr-poor renal epithelial cells into tubular structures on biodegradable polymer scaffold. Pediatrics 98 Suppl (1996) S631
164. Yoo J., Ashkar S., and Atala A. Creation of functional kidney structures with excretion of kidney-like fluid in vivo. Pediatrics 98S (1996) 605
165. Amiel G.E., Yoo J.J., and Atala A. Renal tissue engineering using a collagen-based kidney matrix. Tissue Eng Suppl 6 (2000) 685
166. Matsumura G., Miyagawa-Tomita S., Shin'oka T., Ikada Y., and Kurosawa H. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation 108 (2003) 1729-1734
167. Watanabe M., Shin'oka T., Tohyama S., Hibino N., Konuma T., Matsumura G., Kosaka Y., Ishida T., Imai Y., Yamakawa M., et al. Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. Tissue Eng 7 (2001) 429-439
168. Shinoka T., Breuer C.K., Tanel R.E., Zund G., Miura T., Ma P.X., Langer R., Vacanti J.P., and Mayer Jr. J.E. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg 60 (1995) S513-516
169. Shinoka T., Shum-Tim D., Ma P.X., Tanel R.E., Isogai N., Langer R., Vacanti J.P., and Mayer Jr. J.E. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 115 (1998) 536-545 [discussion 545-536]
170. Shinoka T., Shum-Tim D., Ma P.X., Tanel R.E., Langer R., Vacanti J.P., and Mayer Jr. J.E. Tissue-engineered heart valve leaflets: does cell origin affect outcome?. Circulation 96 (1997) II-102-07
171. Shin'oka T., Imai Y., and Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 344 (2001) 532-533
172. Jawad H., Ali N.N., Lyon A.R., Chen Q.Z., Harding S.E., and Boccaccini A.R. Myocardial tissue engineering: a review. J Tissue Eng Regener Med 1 (2007) 327-342
173. Ott H.C., Matthiesen T.S., Goh S.K., Black L.D., Kren S.M., Netoff T.I., and Taylor D.A. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med (2008)
174. Bhandari R.N., Riccalton L.A., Lewis A.L., Fry J.R., Hammond A.H., Tendler S.J., and Shakesheff K.M. Liver tissue engineering: a role for co-culture systems in modifying hepatocyte function and viability. Tissue Eng 7 (2001) 345-357
175. Fox I.J., Chowdhury J.R., Kaufman S.S., Goertzen T.C., Chowdhury N.R., Warkentin P.I., Dorko K., Sauter B.V., and Strom S.C. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. [see comment]. N Engl J Med 338 (1998) 1422-1426
176. Nieto J.A., Escandon J., Betancor C., Ramos J., Canton T., and Cuervas-Mons V. Evidence that temporary complete occlusion of splenic vessels prevents massive embolization and sudden death associated with intrasplenic hepatocellular transplantation. Transplantation 47 (1989) 449-450
177. Kaufmann P.M., Kneser U., Fiegel H.C., Kluth D., Herbst H., and Rogiers X. Long-term hepatocyte transplantation using three-dimensional matrices. Transplant Proc 31 (1999) 1928-1929
178. Gilbert J.C., Takada T., Stein J.E., Langer R., and Vacanti J.P. Cell transplantation of genetically altered cells on biodegradable polymer scaffolds in syngeneic rats. Transplantation 56 (1993) 423-427